Gentian Diagnostics ASA (DE:6FK) has released an update.
Gentian Diagnostics ASA, an innovative developer of diagnostic tests, announces the appointment of industry veteran Frank Frantzen as Chief Technology Officer (CTO). With over 35 years of experience in the diagnostic industry and significant contributions to the development of major international IVD products, Frantzen brings a wealth of expertise to the company. His previous roles include senior positions at leading firms such as Abbott and his involvement in the creation of groundbreaking products and receipt of prestigious awards.
For further insights into DE:6FK stock, check out TipRanks’ Stock Analysis page.